-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Estrella Immunopharma, Inc. quarterly/annual Return On Equity history and growth rate from 2021 to 2024.
- Estrella Immunopharma, Inc. Return On Equity for the quarter ending June 30, 2024 was -91.7 %, a 184% decline year-over-year.
- Estrella Immunopharma, Inc. annual Return On Equity for 2024 was -91.7 %, a 164% decline from 2023.
- Estrella Immunopharma, Inc. annual Return On Equity for 2023 was 143 %, a 347% increase from 2022.
- Estrella Immunopharma, Inc. annual Return On Equity for 2022 was 31.9 %, a 41% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)